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aBsTRacT 
INTRODUCTION: The introduction of laparoscopic cholecyst­
ectomy was followed by a steep increase in the cholecystec­
tomy rate, which has remained on an unchanged, high level. 
The main indication for cholecystectomy in Denmark in  
cases with uncomplicated gallbladder stones is socially de­
bilitating pain. The objective of the present study was to in­
vestigate whether the indication “socially debilitating pain” 
was reported in the patient’s file when he or she was re­
ferred to surgery. 
METHODS: Hospital files for all patients referred to surgical 
evaluation for uncomplicated gallbladder stones from 
Odense University Hospital’s service area (approximately 
449,000 inhabitants) within a one­year period (2014) were 
reviewed. 
RESULTS: Among 1,003 eligible patients, a total of 516 met 
the inclusion criteria, 407 (78.9%) of whom underwent 
elect ive cholecystectomy. For only 89 (21.9%) of these 407 
patients, the indication of socially debilitating pain was de­
scribed in the patient files.
CONCLUSIONS: Our results may represent overtreatment 
and/or incorrect selection of patients suitable for surgery. 
More and larger prospective cohort studies are warranted 
to elucidate the indications for cholecystectomy in uncom­
plicated gallbladder stones. 
FUNDINg: none.
TRIaL REgISTRaTION: not relevant.
Asymptomatic (“silent”) gallbladder stones are common 
in the general population with a reported prevalence up 
to 22.4% [1, 2]. Within a 20­year observation period, up 
to 18% of these citizens will experience symptoms in the 
form of recurrent abdominal pain, nausea and food in­
tolerance or undergo cholecystectomy due to symp­
toms, and up to 8% will develop complications (choledo­
colithiasis, cholecystitis, cholangitis or pancreatitis) [3]. 
According to national guidelines, laparoscopic chol­
ecystectomy is currently considered the gold standard 
for treatment of symptomatic gallbladder stones [4, 5]. 
However, studies have shown that up to 2% of the pa­
tients who undergo laparoscopic cholecystectomy will 
experience complications to some extent, and up to 
0.63% will suffer from severe complications like bile leak 
or bile duct injuries, which is associated with great mor­
bidity and even with mortality [6]. Furthermore, after 
cholecystectomy for uncomplicated gallbladder stones, 
4­47% will experience persistent abdominal symptoms 
(post­cholecystectomy syndrome) depending on the  
patient selection [7, 8]. Therefore, conservative treat­
ment with watchful waiting might be a preferable alter­
native to operation in cases with mild or rare symptoms. 
A large cohort study by Shabanzadeh DM et al found 
that epigastrial pain, hours of pain duration and need of 
pain medication were correlated to later events/compli­
cations and that these factors may guide patients and 
physicians in the choice between cholecystectomy or 
watchful waiting [9]. 
In Denmark, the number of cholecystectomies in­
creased from approximately 67 operations per 100,000 
inhabitants in 1989 to 143 operations per 100,000 in­
habitants in 2003 [10]. The introduction of laparoscopic 
surgery and/or an increased demand for operation 
among patients might be the explanation [1, 10]. On this 
background, the Danish Health Authority released an  
evidence­based recommendation stating that the main 
indication for cholecystectomy in uncomplicated cases 
with gallbladder stones should be socially debilitating 
pain, which by nature is very dependent on individual 
circumstances [4]. Following this new recommendation, 
one would expect the cholecystectomy rate to decrease, 
but in 2014 we carried out 138 operations per 100,000 
inhabitants [11] leaving the cholecystectomy rate on an 
unchanged high level for more than a decade. The same 
trend has been observed in Sweden with a slight de­
crease from 161 operations per 100,000 inhabitants in 
1998 to 137 per 100,000 inhabitants in 2013 [12]. 
The objective of the present study was to investi­
gate whether the indication “socially debilitating pain” 
was reported in the patient’s file when he or she was  
referred to surgery. Our hypothesis was that socially 
debili tating pain as an indication for cholecystectomy 
was not well described or defined in the patient records 
and that only a minority of patients were referred for 
conservative treatment. 
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mEThOds
Patients
We reviewed files for patients above 15 years of age 
who were referred to surgical evaluation for uncompli­
cated gallbladder stones within Odense University Hos­
pital’s service area (approximately 449,000 inhabitants) 
in Denmark from 1 January to 31 December 2014. Pa­
tients were identified in the hospital’s electronic case  
record system using The International Classification of 
Diseases (ICD)­10 by searching for the following codes: 
DK80, DK802, DK802A, DK802D­F, DK805, DK805J­K and 
DK808. Each patient file was reviewed for specific data 
regarding demographics, clinical symptoms, patient 
preference for treatment, actual treatment, earlier hos­
pital admissions, diagnostic tool, comorbidity, biochem­
istry and finally whether “debilitating pain” was de­
scribed.   
The Danish Patient Safety Authority (file no: 3­3013­
1705/1/) and The Danish Data Protection Agency (file 
no: 16/18475) approved the project prior to data collec­
tion, and OPEN Redcap was used as the study database.  
inclusion and exclusion criteria
We defined uncomplicated gallbladder stones as fol­
lows: Patients with verified gallstone(s) (ultrasonic (UL) 
or by magnetic resonance imaging (MRI)/computed 
tom ography (CT)), who were referred to hospital for 
evaluation of abdominal pain with or without dyspeptic 
symptoms. All patients with clinical, biochemical or ra­
diographic signs of gallbladder inflammation, obstruc­
tion of bile ducts, malignancy or other abdominal abnor­
malities were excluded (Table 1). 
definition of “socially debilitating pain”
To ensure consistency throughout the data collection, 
we agreed on defining socially debilitating pain as any 
description that considered the influence of the symp­
toms on the patient’s life. This could be regarding work, 
e.g. sick leave, social skills, e.g. unable to perform daily 
activities, psychological, e.g. anxiety for new attacks of 
pain or if the patient felt the situation was unsustain­
able. Consequently, all files only describing symptoms in 
an objective/quantitative manner were categorised as 
non­debilitating pain. 
statistics  
Statistical analysis was preformed using STATA 14.0.  
For categorical data, we used Pearson’s chi squared test 
unless the variables were small (< 10), in which case we 
used Fisher’s exact test. For continuous data that were 
normally distributed, we used Student’s t­test. Data  
with a non­normal distribution were tested by a non­
param etric k­sample test on the equality of medians.  
A p­value < 0.05 was considered statistically significant.  
Trial registration: not relevant.
REsUlTs
Overall demographics for included patients
Of the 1,003 patients referred to surgical evaluation in 
the observation period, 516 met the inclusion criteria. 
The female:male ratio was 4:1. The mean age was 48 
years and the mean body mass index (BMI) was 29. In 
422 patients, gallstone was verified by UL, 31 were ver­
ified by MRI, 15 by CT and 48 had unknown diagnostic 
imaging because the diagnostic procedures had been 
performed outside of our region.
surgery versus watchful waiting 
A total of 407 (78.9%) of the included 516 patients  
underwent elective cholecystectomy. Those who under­
went cholecystectomy were significantly younger than 
those who did not with a mean age of 46 and 56, re­
spect ively (p < 0.001). There was no significant differ­
ence between the two groups regarding sex or BMI. In 
the group of patients who underwent cholecystectomy 
(surgery group (SG)) significantly more reported symp­
toms once/week or more often and with a duration of 
more than three months than in the watchful waiting 
TaBlE 1
Eliglible patients and the reasons for exclusion. The values are n (%).
Included     516 (51.4)
Excluded     487 (48.6)
Cholecystitis: earlier/current     134 (13.4)
Choledocolithiasis: earlier/current       94 (9.4)
Referred to another region or private hospital       48 (4.8)
Never evaluated by sugeon       35 (3.5)
Pancreatitis caused by gallstone       30 (3.0)
Gall bladder polyps with 0 stones       26 (2.6)
Wrong ICD­10 code       20 (2.0)
Jaundice: earlier/current       19 (1.9)
Had cholecystectomy before 2014       15 (1.5)
0 gall bladder stones: UL/MRI/CT       15 (1.5)
Cholangitis: earlier/current       14 (1.4)
Other reasons         9 (0.9)
Suspicion of cholangiocarcinoma/pancreas cancer         8 (0.8)
Suspicion of choledocolithiasis         6 (0.6)
< 15­yr­old         4 (0.4)
Medical induced effect on liver         3 (0.3)
Patients preference due to comorbidity         2 (0.2)
Stenosis in biliary system         2 (0.2)
Internal herniation         2 (0.2)
Patient died before surgical evaluation         1 (0.1)
Patients, total 1,003 (100.0)
CT = computed tomography; ICD = International Classification of Disease;
MRI = magnetic resonance imaging; UL = ultrasonic.
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group (WW). The values were 44.5% versus 16.5% (p = 
0.001) and 59.5% versus 47.7% (p = 0.03), respectively 
(Table 2). In both groups, pain was most often located 
under the right costal margin (68.6% for SG versus 58.7% 
for WW) followed by “atypical pain location” (35.6% ver­
sus 37.6%) and epigastric pain (23.6% versus 18.3%).  
Socially debilitating pain was more often described in 
the SG and more patients had a preference for surgery 
than in the WW (21.9% versus 4.6%; p < 0.001) and 
(35.1% versus 4.6%; p < 0.001), respectively. As to hos­
pital admissions caused by gallbladder stones prior to 
surgical evaluation, both the number of patients and the 
mean number of admissions per patient in the SG was 
higher than in the WW. The numbers being 80 versus 11 
and 0.28 versus 0.11 (p = 0.02 for both), respectively 
(Table 2).  
In the WW group, more patients had bilirubin and 
alkaline phosphatase (ALP) levels above the reference 
value than in the SG, 20.2% versus 12.5% (p = 0.042) and 
34.9% versus 21.9% (p = 0.005), respectively (Table 2). 
Also, patients in the WW had a higher frequency of 
hyper tension, diabetes and ischaemic heart disease, 
28.4% versus 20.6% (p = 0.002), 8.3% versus 4.7% (p = 
0.039) and 16.5% versus 7.4% (p < 0.001), respectively. 
More patients in the SG had previous abdominal surgery 
than in the WW (38.3% versus 19.3%; p = 0.007). 
American Society of Anesthesiologists (ASA)­scores 1 
and 2 were more frequent for patients in the SG: 47.9% 
versus 9.2% and 40.8% versus 14.7% (p = 0.007), for 
both. While ASA­score 3 was more frequent in the WW 
group (4.6% versus 2.9%; p = 0.007) (Table 2).
socially debilitating pain
Of the 407 patients who underwent cholecystectomy, 
only 89 (21.9%) had debilitating pain described in their 
files, and of these 89 patients more had experienced 
symptoms for longer than three months compared with 
the group without this description (69.7% versus 56.6%; 
p = 0.027) (Table 3). In the group without a description 
of debilitating pain, more patients had a history of previ­
ous abdominal surgery (29.2% versus 40.9%; p = 0.045) 
(Table 3). All other variables were similar in the two 
groups (Table 3). 
discUssiOn
indication for surgery
The majority of patients (78.9%) who were referred to 
hospital for uncomplicated gallbladder stones were sub­
sequently referred for a cholecystectomy. Only 21.9% of 
these patients had the indication “socially debilitating 
pain” described in their files, which should be the main 
indication according to national recommendations. 
However, significantly more patients in the SG had a his­
tory of more frequent symptoms and longer symptom 
TaBlE 2
Comparison of patients who underwent cholecystectomy versus being referred to watchful waiting. 
surgery
(n = 407)
Watchful waiting
(n = 109) p-value
Frequency of symptoms within last 3 mo.s, n (%)
≤ once/wk 104 (25.55) 42 (38.53) < 0.001
> once/wk 181 (44.47) 18 (16.51)
Unknown 122 (29.98) 49 (44.95)  –
Overall duration of symptoms, n (%)
≤ 3 mo.s 77 (18.92) 27 (24.77)
> 3­6 mo.s 60 (14.74)  7 (6.42)
0.102
> 6 mo.s­1 yr 51 (12.53) 12 (11.01)
> 1 yr 131 (32.19) 33 (30.28)
> 3 mo.s, total 242 (59.46) 52 (47.71) 0.028
Unknown   88 (21.62) 30 (27.52)  –
Location of pain, n (%) 
Epigastric 96 (23.6) 20 (18.3) 0.245
Right costal margin 279 (68.6) 64 (58.7) 0.053
Right flank   7 (1.7)  1 (0.9) 1
Atypical localization 145 (35.6) 41 (37.6) 0.701
Unknown   4 (1.0)  5 (4.6)  –
Debilitating pain described in file, n (%)  89 (21.87)  5 (4.59) < 0.001
Patient preference, n (%) 
Operation 143 (35.14)  5 (4.59) < 0.001
Watchful waiting   0 32 (29.36)
Unknown 264 (64.86) 72 (66.06)  –
Admissions
Patients with earlier hospital admission, n (%)  80 (19.66) 11 (10.09) 0.02
Admissions, total, n 115 12  –
Admissions/patient, n, mean (range) 0.28 (0­4) 0.11 (0­2) 0.02
Biochemistry, n [missing] (%)  
Patients with bilirubin level > 25 μmol/l 51 [42] (12.53) 22 [20] (20.18) 0.042
Patients with alkaline phosphatase level  
> 105 U/l
89 [40] (21.87) 38 [15] (34.86) 0.005
Patients with alanine aminotransferase level 
> 45 U/l
116 [37] (28.50) 35 [15] (32.11) 0.462
Previous abdominal surgery, n (%)
Yes 156 (38.33) 21 (19.27) 0.007
No 251 (61.67) 69 (63.30)
Unknown   0 19 (17.43)  –
Comorbidity, n (%)
Hypertension 84 (20.64) 31 (28.44) 0.002
Diabetes 19 (4.67)  9 (8.26) 0.039
Ischaemic heart disease 30 (7.37) 18 (16.51) < 0.001
Pulmonary disease 29 (7.13)  7 (6.42) 0.653
Kidney disease  2 (0.49)  0 1
Liver disease  1 (0.25)  0 1
ASA-score, n (%)
1 195 (47.91) 10 (9.17) 0.007
2 166 (40.79) 16 (14.68)
3  12 (2.95)  5 (4.59)
4    1 (0.25)  0
Unknown  33 (8.11) 78 (71.56)  –
ASA = American Society of Anesthesiologists. 
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duration. In addition, they had a higher rate of previous 
hospital admissions due to gallbladder stones and a 
higher preference for surgery. On the other hand, WW 
patients tended to be frailer with a higher frequency of 
comorbidities; hypertension, diabetes and ischaemic 
heart disease and they were, on average, ten years older 
than the SG patients, which may explain the choice of 
conservative treatment. This information may indicate 
that other indications might have played an important 
role in selecting patients for surgery or watchful waiting. 
Due to missing data in the WW, it is difficult to draw any 
final conclusions from ASA scores and previous abdom­
inal surgery, and there is no obvious explanation for the 
fact that more patients on watchful waiting had ele­
vated levels of bilirubin and ALP compared with the sur­
gery group. 
The explanation for patients being referred to chol­
ecystectomy without the proper indication of socially 
debilitating pain described in their files cannot be dis­
cerned from the present study. That some patients with 
a preference for surgery had their desire met by the sur­
geon could explain some of the cases, but this explana­
tion will hardly account for them all. Similarly, we cannot 
determine what caused a persistent high cholecystecto­
my rate after the new recommendations were released 
in 2006, but it might be an expression of the prolonged 
process needed to implement new evidence in clinical 
practice.
That patients are being referred for cholecystec­
tomy without the proper indication could have extensive 
consequences for the patient and for society. The fre­
quency of serious complications to cholecystectomy are 
not negligible, but have to be weighed against the fact 
that up to 8% of patients will, over time, develop com­
plications to gallbladder stones when treated conserva­
tively [3]. It is noteworthy that we still do not know who 
will benefit most from surgery or from watchful waiting 
[13]. The problem with patient selection for cholecystec­
tomy seems to be relevant worldwide. Though several 
countries have their own guidelines, Van Dijk et al found 
that many of these are not suitable for clinical practice, 
either because of a low level of evidence or due to a lack 
of consensus [14]. Thus, a great variation in the chole­
cystectomy rate within the Scandinavian countries has 
been reported, with markedly higher rates in Finland 
and Sweden even though the highest prevalence of gall­
stones has been observed in Norway [15]. 
strengths and limitations 
The present study faces the same limitations as most 
retrospective studies in its inability to trail important 
data if these are missing. Consequently, we had to de­
fine a very rigid and simple definition of “socially debili­
tating pain”. This is problematic and our definition might 
be unprecise or even incorrect. Also, our results are very 
dependent on the patients’ records, which could be in­
complete. Therefore, the present study cannot deter­
mine whether the indication for cholecystectomy was 
TaBlE 3
Comparison of all patients who underwent cholecystectomy as to whether they had debilitating pain 
described in their file.
debilitating pain
described
(n = 89)
not described
(n = 318) p-value
Frequency of symptoms within last 3 mo.s, n (%) 
≤ once/wk 19 (21.35)   85 (26.73)
0.076
> once/wk 50 (56.18) 131 (41.19)
Unknown 20 (22.47) 102 (32.08) –
Overall duration of symptoms, n (%)   
≤ 3 mo.s 17 (19.10)   60 (18.87)
> 3­6 mo.s 19 (21.35)   41 (12.89)
0.581
> 6 mo.s­1 yr 12 (13.48)   39 (12.26)
> 1 yr 31 (34.83) 100 (31.45)
> 3 mo.s, total 62 (69.66) 180 (56.60) 0.027
Unknown 10 (11.24)   78 (24.53)  –
Location of pain, n (%)   
Epigastric 19 (21.35)   77 (24.21) 0.574
Right costal margin 63 (70.79) 216 (67.92) 0.607
Right flank   2 (2.25)     5 (1.57) 0.65
Atypical localization 34 (38.20) 111 (34.91) 0.566
Unknown   0     4 (1.26) –
Patient preference, n (%)   
Operation 36 (40.45) 107 (33.65)
Unknown 53 (59.55) 211 (66.35)
0.235
Admissions
Patients with earlier hospital admission, n (%)   17 (19.10)  63 (19.81) 0.882
Admissions, total, n 25  90 –
Admissions/patient, n, mean (range) 0.28 (0­4)   0.28 (0­5) 0.882
Biochemistry, n [missing] (%)  
Patients with bilirubin level > 25 μmol/l 11 [10] (12.36)  40 [32] (12.58) 0.956
Patients with alkaline phosphatase level  
> 105 U/l
20 [11] (22.47)  69 [29] (21.70) 0.876
Patients with alanine aminotransferase level  
> 45 U/l
27 [10] (30.34)  89 [27] (27.99) 0.664
Previous abdominal surgery, n (%)   
Yes 26 (29.21) 130 (40.88)
No 63 (70.79) 188 (59.12)
0.045
Comorbidity, n (%)   
Hypertension 14 (15.73)  70 (22.01) 0.196
Diabetes   5 (5.62)  14 (4.40) 0.579
Ischaemic heart disease   6 (6.74)  24 (7.55) 1.000
Pulmonary disease   4 (4.49)  25 (7.86) 0.355
Kidney disease   1 (1.12)   1 (0.31) 0.39
Liver disease   1 (1.12)   0 0.219
ASA-score, n (%)   
1 49 (55.06) 146 (45.91)
2 31 (34.83) 135 (42.45)
3  1 (1.12)  11 (3.46)
0.33
4  0   1 (0.31)
Unknown  8 (8.99)  25 (7.86) –
ASA = American Society of Anesthesiologists. 
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too liberal or not, or whether the patients benefited 
from the decision made with respect to surgery or 
watchful waiting. Only large prospective trials with well­
defined indications for cholecystectomy may provide 
this answer. A minority of the included patients was sub­
mitted to the emergency department because of ab­
dominal pain, which might influence the routine setting 
for evalu ation for surgery and thereby cause bias favour­
ing surgery. 
For patients who were selected for conservative 
treatment, there were often missing data because their 
personal records were not as complete as those of pa­
tients who were referred for surgery. Therefore, it was 
difficult to make final conclusions between the two 
groups for some variables, e.g. ASA score, even though 
we found a statistically significant difference. Through­
out the statistical work, the variable “unknown” repre­
senting missing data was omitted to minimise the risk of 
bias, but this is still problematic and any interpretation 
of our results should be made with caution – especially 
when the size of “unknown” data is unequal between 
two groups. Also, some of the variables/events only oc­
curred a few times within our population, leaving small 
data amounts for statistical analysis.   
The strengths of the present study are that all eli­
gible cases from a well­defined catchment area were in­
cluded within a continuum of one year. Furthermore, all 
files were reviewed by a single researcher to ensure a 
consistent interpretation of the data throughout the en­
tire data collection. 
cOnclUsiOns
For more than three quarters of the patients with un­
complicated gallbladder stones referred for cholecystec­
tomy, the generally accepted main indication of socially 
debilitating pain was not described in medical files. This 
is problematic and could lead to overtreatment and/or 
incorrect selection of patients suitable for surgery. More 
and larger prospective studies are warranted to explore 
this topic. 
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